146 related articles for article (PubMed ID: 25110904)
1. Combating unmeasured confounding in cross-sectional studies: evaluating instrumental-variable and Heckman selection models.
DeMaris A
Psychol Methods; 2014 Sep; 19(3):380-97. PubMed ID: 25110904
[TBL] [Abstract][Full Text] [Related]
2. Assessing causal treatment effect estimation when using large observational datasets.
John ER; Abrams KR; Brightling CE; Sheehan NA
BMC Med Res Methodol; 2019 Nov; 19(1):207. PubMed ID: 31726969
[TBL] [Abstract][Full Text] [Related]
3. The impact of unmeasured within- and between-cluster confounding on the bias of effect estimatorsof a continuous exposure.
Li Y; Lee Y; Port FK; Robinson BM
Stat Methods Med Res; 2020 Aug; 29(8):2119-2139. PubMed ID: 31694489
[TBL] [Abstract][Full Text] [Related]
4. Sample size importantly limits the usefulness of instrumental variable methods, depending on instrument strength and level of confounding.
Boef AG; Dekkers OM; Vandenbroucke JP; le Cessie S
J Clin Epidemiol; 2014 Nov; 67(11):1258-64. PubMed ID: 25124167
[TBL] [Abstract][Full Text] [Related]
5. Analysis approaches to address treatment nonadherence in pragmatic trials with point-treatment settings: a simulation study.
Hossain MB; Mosquera L; Karim ME
BMC Med Res Methodol; 2022 Feb; 22(1):46. PubMed ID: 35172746
[TBL] [Abstract][Full Text] [Related]
6. Bias testing, bias correction, and confounder selection using an instrumental variable model.
Yeob Choi B; Fine JP; Alan Brookhart M
Stat Med; 2020 Dec; 39(29):4386-4404. PubMed ID: 32854161
[TBL] [Abstract][Full Text] [Related]
7. The missing cause approach to unmeasured confounding in pharmacoepidemiology.
Abrahamowicz M; Bjerre LM; Beauchamp ME; LeLorier J; Burne R
Stat Med; 2016 Mar; 35(7):1001-16. PubMed ID: 26932124
[TBL] [Abstract][Full Text] [Related]
8. Adjusting for unmeasured confounding in nonrandomized longitudinal studies: a methodological review.
Streeter AJ; Lin NX; Crathorne L; Haasova M; Hyde C; Melzer D; Henley WE
J Clin Epidemiol; 2017 Jul; 87():23-34. PubMed ID: 28460857
[TBL] [Abstract][Full Text] [Related]
9. On a preference-based instrumental variable approach in reducing unmeasured confounding-by-indication.
Li Y; Lee Y; Wolfe RA; Morgenstern H; Zhang J; Port FK; Robinson BM
Stat Med; 2015 Mar; 34(7):1150-68. PubMed ID: 25546152
[TBL] [Abstract][Full Text] [Related]
10. Unifying instrumental variable and inverse probability weighting approaches for inference of causal treatment effect and unmeasured confounding in observational studies.
Liu T; Hogan JW
Stat Methods Med Res; 2021 Mar; 30(3):671-686. PubMed ID: 33213292
[TBL] [Abstract][Full Text] [Related]
11. Monte Carlo sensitivity analysis for unmeasured confounding in dynamic treatment regimes.
Rose EJ; Moodie EEM; Shortreed SM
Biom J; 2023 Jun; 65(5):e2100359. PubMed ID: 37017498
[TBL] [Abstract][Full Text] [Related]
12. The effect of unmeasured confounders on the ability to estimate a true performance or selection gradient (and other partial regression coefficients).
Walker JA
Evolution; 2014 Jul; 68(7):2128-36. PubMed ID: 24635123
[TBL] [Abstract][Full Text] [Related]
13. Estimating linear regression models in the presence of a censored independent variable.
Austin PC; Hoch JS
Stat Med; 2004 Feb; 23(3):411-29. PubMed ID: 14748036
[TBL] [Abstract][Full Text] [Related]
14. Bayesian sensitivity analysis for unmeasured confounding in causal mediation analysis.
McCandless LC; Somers JM
Stat Methods Med Res; 2019 Feb; 28(2):515-531. PubMed ID: 28882092
[TBL] [Abstract][Full Text] [Related]
15. Endogeneity bias in the absence of unobserved heterogeneity.
Berg GD; Mansley EC
Ann Epidemiol; 2004 Sep; 14(8):561-5. PubMed ID: 15350955
[TBL] [Abstract][Full Text] [Related]
16. [Sensitivity analysis method for unmeasured confounding interference in observational study].
Wang DH; You DF; Huang LL; Zhao Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1470-1475. PubMed ID: 31838823
[No Abstract] [Full Text] [Related]
17. Evaluating possible confounding by prescriber in comparative effectiveness research.
Franklin JM; Schneeweiss S; Huybrechts KF; Glynn RJ
Epidemiology; 2015 Mar; 26(2):238-41. PubMed ID: 25643103
[TBL] [Abstract][Full Text] [Related]
18. Instrumental variable analysis in the presence of unmeasured confounding.
Zhang Z; Uddin MJ; Cheng J; Huang T
Ann Transl Med; 2018 May; 6(10):182. PubMed ID: 29951504
[TBL] [Abstract][Full Text] [Related]
19. How unmeasured confounding in a competing risks setting can affect treatment effect estimates in observational studies.
Barrowman MA; Peek N; Lambie M; Martin GP; Sperrin M
BMC Med Res Methodol; 2019 Jul; 19(1):166. PubMed ID: 31366331
[TBL] [Abstract][Full Text] [Related]
20. Methods to control for unmeasured confounding in pharmacoepidemiology: an overview.
Uddin MJ; Groenwold RH; Ali MS; de Boer A; Roes KC; Chowdhury MA; Klungel OH
Int J Clin Pharm; 2016 Jun; 38(3):714-23. PubMed ID: 27091131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
